Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model ; volume:18 ; number:1 ; day:5 ; month:2 ; year:2014 ; pages:1-10 ; date:2.2014
Critical care ; 18, Heft 1 (5.2.2014), 1-10, 2.2014
- Urheber
- Beteiligte Personen und Organisationen
-
van Ryn, Joanne
Spronk, Henri MH
Rossaint, Rolf
SpringerLink (Online service)
- DOI
-
10.1186/cc13717
- URN
-
urn:nbn:de:1111-201604238245
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grottke, Oliver
- van Ryn, Joanne
- Spronk, Henri MH
- Rossaint, Rolf
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Idarucizumab: A novel antidote for reversal of dabigatran
The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination
Thrombocytopenia induced by dabigatran: two case reports
Exfoliative esophagitis and esophageal ulcer induced by dabigatran
Prothrombotische Wirkung von Dabigatran während der arteriellen Thrombose
Der Einfluss von Dabigatran und Rivaroxaban auf die Thrombozytenfunktion
Idarucizumab for a traumatic head injury patient taking dabigatran
Dabigatran Excess: Case Report and Review of the Literature
Extensive dabigatran-induced exfoliative esophagitis harboring squamous cell carcinoma
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Idarucizumab: A novel antidote for reversal of dabigatran
The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination
Thrombocytopenia induced by dabigatran: two case reports
Exfoliative esophagitis and esophageal ulcer induced by dabigatran
Prothrombotische Wirkung von Dabigatran während der arteriellen Thrombose
Der Einfluss von Dabigatran und Rivaroxaban auf die Thrombozytenfunktion
Idarucizumab for a traumatic head injury patient taking dabigatran
Dabigatran Excess: Case Report and Review of the Literature
Extensive dabigatran-induced exfoliative esophagitis harboring squamous cell carcinoma
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
Idarucizumab: A novel antidote for reversal of dabigatran
The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination
Thrombocytopenia induced by dabigatran: two case reports
Exfoliative esophagitis and esophageal ulcer induced by dabigatran
Prothrombotische Wirkung von Dabigatran während der arteriellen Thrombose
Der Einfluss von Dabigatran und Rivaroxaban auf die Thrombozytenfunktion
Idarucizumab for a traumatic head injury patient taking dabigatran
Dabigatran Excess: Case Report and Review of the Literature
Extensive dabigatran-induced exfoliative esophagitis harboring squamous cell carcinoma